Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments GlobeNewswire November 07, 2025 Single ascending dose data readout for VTP-1000 expected before the end of 2025 Enrollment advancing in multiple ascending dose part of the AVALON trial; data expected in the second half of 2026 Proposed combination with Clywedog Therapeutics Inc. […]